Ladenburg Thalmann Financial Services (AMEX:LTS)
The Company is engaged in retail and institutional securities brokerage, investment banking services, asset management services and investment activities through its subsidiary.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
Recs
Now that many of the traditional brokers have become behemoths, LTS can take its proper place among those that can nimbly take market share and adapt to this new environment. Management has wisely taken advantage of the decimation in the industry to recruit excellent new talent. Over a couple of years or so this co. should return to its highs of $9 plus.
Recs
interesting movements in stock
Recs
Great Mangement
Recs
Severely undervalued
Recs
Dr Phillip Frost and his ability to grow everything over time.
Recs
lts is a fine stock and i watched it grow from 2.30 to over 3 in a short period of time. it wasnt affected by the major correction 2 weeks ago and i believe it will slowly incine and perhaps have a few very strong jumps. buy now and keep buying if it continues to drop. sell around $4.
Recs
Getting to be a climber.
Recs
Millionaire turn around PRO takes over company.
Recs
Insider buying
Recs
Stock is moving up on high volume. Heavy insider buying.
Recs
Downtrend in earnings since 2001, no cash flow. Pure speculative buy based on recent insider buys. Earnings should be reported within the next 2 to 3 weeks. Is LTS turning the corner? Maybe. 2006 is looking up. For the nine months ended September 30, 2006 revenues were $32,430,000, compared to revenues of $21,186,000 for the first nine months of 2005. The Company recorded net income of $3,977,000, or $0.03 per share, in the 2006 nine-month period, compared to a net loss of $26,184,000, or $0.26 per share, in the 2005 nine-month period.
Recs
I've watched and read about this company and have invested in it. I believe they are getting their act together and you will see it in the price.
Recs
Dr. Frost Has determined to make LT his greatest achievement. What he has accomplished with Key and Ivax are steps to this end.
Recs
Becuase I said so.
Recs
I bot at $1.16. Lots of insider buying. Phillip Frost is founder of Key Pharm and IVAX and made 2 billion selling them. He owns $48 million shares of this and is moving the corp to Miami to concentrate on mid-mkt M&A in Florida. If he pulls it off this the third corp success. Moving to old IVAX headquarters. He is also on board of Grumman and Teva
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 17 of 17